Literature DB >> 33573655

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome.

Stephen L Atkin1, Alexandra E Butler2, Abu Saleh Md Moin3, Manjula Nandakumar3, Thozhukat Sathyapalan4.   

Abstract

Entities:  

Keywords:  Biomarkers; COVID-19; Coagulation factors; Platelet degranulation; Polycystic ovary syndrome; SARS-CoV-2

Year:  2021        PMID： 33573655      PMCID： PMC7876982          DOI： 10.1186/s12967-021-02723-7

Source DB:  PubMed          Journal:  J Transl Med        ISSN： 1479-5876            Impact factor:   5.531


× No keyword cloud information.
  8 in total

1.  Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Metabol Open       Date:  2020-08-18

2.  Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.

Authors:  Bülent O Yildiz; Ibrahim C Haznedaroğlu; Serafettin Kirazli; Miyase Bayraktar
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

Review 3.  Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.

Authors:  Winifred Mak; Anuja Dokras
Journal:  Semin Thromb Hemost       Date:  2009-10       Impact factor: 4.180

4.  Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.

Authors:  Baha Oral; Betül Mermi; Müfide Dilek; Güçhan Alanoğlu; Recep Sütçü
Journal:  Gynecol Endocrinol       Date:  2009-02       Impact factor: 2.260

5.  Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.

Authors:  Alexander Juusela; Munir Nazir; Martin Gimovsky
Journal:  Am J Obstet Gynecol MFM       Date:  2020-04-03

6.  Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects.

Authors:  Hassan Kahal; Anna Halama; Ahmed Aburima; Aditya M Bhagwat; Alexandra E Butler; Johannes Graumann; Karsten Suhre; Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

7.  Large-Scale Multi-omic Analysis of COVID-19 Severity.

Authors:  Katherine A Overmyer; Evgenia Shishkova; Ian J Miller; Joseph Balnis; Matthew N Bernstein; Trenton M Peters-Clarke; Jesse G Meyer; Qiuwen Quan; Laura K Muehlbauer; Edna A Trujillo; Yuchen He; Amit Chopra; Hau C Chieng; Anupama Tiwari; Marc A Judson; Brett Paulson; Dain R Brademan; Yunyun Zhu; Lia R Serrano; Vanessa Linke; Lisa A Drake; Alejandro P Adam; Bradford S Schwartz; Harold A Singer; Scott Swanson; Deane F Mosher; Ron Stewart; Joshua J Coon; Ariel Jaitovich
Journal:  Cell Syst       Date:  2020-10-08       Impact factor: 10.304

8.  Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.

Authors:  Ting Shu; Wanshan Ning; Di Wu; Jiqian Xu; Qiangqiang Han; Muhan Huang; Xiaojing Zou; Qingyu Yang; Yang Yuan; Yuanyuan Bie; Shangwen Pan; Jingfang Mu; Yang Han; Xiaobo Yang; Hong Zhou; Ruiting Li; Yujie Ren; Xi Chen; Shanglong Yao; Yang Qiu; Ding-Yu Zhang; Yu Xue; You Shang; Xi Zhou
Journal:  Immunity       Date:  2020-10-20       Impact factor: 31.745
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.